BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 6444445)

  • 21. [Efficacy of postoperative adjuvant chemotherapy for colorectal cancer].
    Nozoe Y; Ogata Y; Miyagi Y; Nakagawa M; Matono K; Sasatomi T; Araki Y; Shirouzu K
    Gan To Kagaku Ryoho; 2002 Jan; 29(1):67-72. PubMed ID: 11816480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Survival of patients with liver metastasis from colorectal cancer by different modes of therapy: a report of 363 cases].
    Xu JM; Qin XY; Zhong YS; Wei Y; Fan J; Zhou J; Qin LX; Wang JH; Yan ZP; Cheng JM; Wu ZH
    Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):54-7. PubMed ID: 17575696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New approaches to assessing and treating early-stage colon and rectal cancers: cooperative group strategies for assessing optimal approaches in early-stage disease.
    Benson AB
    Clin Cancer Res; 2007 Nov; 13(22 Pt 2):6913s-20s. PubMed ID: 18006800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The current status of postoperative adjuvant chemotherapy for colorectal cancer].
    Kodaira S
    Gan To Kagaku Ryoho; 1997 Aug; 24(10):1230-8. PubMed ID: 9279341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety of intravenous administration of a canarypox virus encoding the human wild-type p53 gene in colorectal cancer patients.
    Menon AG; Kuppen PJ; van der Burg SH; Offringa R; Bonnet MC; Harinck BI; Tollenaar RA; Redeker A; Putter H; Moingeon P; Morreau H; Melief CJ; van de Velde CJ
    Cancer Gene Ther; 2003 Jul; 10(7):509-17. PubMed ID: 12833131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colorectal carcinoma in different age groups: a population-based investigation.
    Fante R; Benatti P; di Gregorio C; De Pietri S; Pedroni M; Tamassia MG; Percesepe A; Rossi G; Losi L; Roncucci L; Ponz de Leon M
    Am J Gastroenterol; 1997 Sep; 92(9):1505-9. PubMed ID: 9317073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Adjuvant immunochemotherapy with long-term OK-432 administration in colorectal cancer].
    Kikkawa N; Sasai H; Kawahara T
    Gan To Kagaku Ryoho; 1984 Oct; 11(10):2163-9. PubMed ID: 6486832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Invited commentary. Gender influences treatment and survival in colorectal cancer surgery.
    Finlayson E
    Dis Colon Rectum; 2009 Dec; 52(12):1991-3. PubMed ID: 19934919
    [No Abstract]   [Full Text] [Related]  

  • 31. Subsequent cancer in patients with chronic lymphocytic leukemia--a possible immunologic mechanism.
    Greene MH; Hoover RN; Fraumeni JF
    J Natl Cancer Inst; 1978 Aug; 61(2):337-40. PubMed ID: 277720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colorectal cancer in Singapore: preliminary report of the Colorectal Cancer Project from the University Department of Surgery, NUS.
    Goh HS; Ti TK; Rauff A; Foong WC; Lee YS
    Singapore Med J; 1985 Feb; 26(1):65-72. PubMed ID: 4023726
    [No Abstract]   [Full Text] [Related]  

  • 33. Follow-up study of adjuvant chemoimmunotherapy in colorectal carcinoma after definitive surgery.
    Sarker SK; Choudhary R; Subhas P; Vora LS; Banerjee AK
    Indian J Cancer; 1985 Jun; 22(2):113-20. PubMed ID: 3842126
    [No Abstract]   [Full Text] [Related]  

  • 34. The Twin Tiers Community Clinical Oncology Program (TTCCOP) experience: the first year.
    Enck RE; Boselli B; Rosencrans H; Maiden C; Rogers B
    Prog Clin Biol Res; 1986; 216():417-22. PubMed ID: 3523535
    [No Abstract]   [Full Text] [Related]  

  • 35. ADJUVANT CHEMOTHERAPY IN CANCER OF THE LARGE BOWEL. AN INTERIM REPORT OF THE VETERANS ADMINISTRATION SURGICAL ADJUVANT CANCER CHEMOTHERAPY STUDY.
    DWIGHT RW
    Am J Surg; 1964 Apr; 107():609-13. PubMed ID: 14136347
    [No Abstract]   [Full Text] [Related]  

  • 36. Severe polyneuropathy and motor loss after intrathecal thiotepa combination chemotherapy: description of two cases.
    Martín Algarra S; Henriquez I; Rebollo J; Artieda J
    Anticancer Drugs; 1990 Oct; 1(1):33-5. PubMed ID: 2131034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant therapy trials.
    JAMA; 1979 Sep; 242(13):1347. PubMed ID: 480552
    [No Abstract]   [Full Text] [Related]  

  • 38. Assessing the effectiveness of follow-up care for colorectal cancer: a great conceptual and methodological challenge for clinical oncology.
    Liberati A; Torri V; Apolone G
    Ann Oncol; 1997 Nov; 8(11):1059-62. PubMed ID: 9426324
    [No Abstract]   [Full Text] [Related]  

  • 39. [Adrenal function test as an indicator of the sensitivity of the hematopoietic system to Thio-TEPA in the combined and complex therapy of cancer of the uterine corpus].
    Khyl'ko AS; Syrota IG
    Pediatr Akus Ginekol; 1971; 4():57-9. PubMed ID: 5004804
    [No Abstract]   [Full Text] [Related]  

  • 40. [Adverse effect of thio tepa on the hemopoiesis and complications arising with it].
    Andriukin AA; Vinogradova ON; Akhtomova LV
    Sov Med; 1968 Sep; 31(9):127-9. PubMed ID: 4989665
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.